Both IFN-α and IFN-γ have been reported to decrease the amount of HPV-18 E6 and E7 transcripts in HeLa cells, and high-dose IFN-α has been utilized as a form of adjuvant therapy to treat melanoma as well as to clear subclinical and latent HPV infections [33,34,35]. Here, IFNG is linked to melanoma.